The Covid-19 vaccine trials are finally starting to move forward, and now a vaccine trial could be on the horizon.
A team of scientists working on the vaccine trial will now be able to move on to the next step: going public.
Vaccine researchers are now in the process of getting the final approval needed to get the trial off the ground.
The Covid trial is being run by the Vaccine Advisory Committee, which is made up of experts in medicine and public health.
So far, the committee has approved a single vaccine, the Covid19 vaccine, as well as a series of vaccines and trials of other medicines.
This is an important step, and it could mean the vaccine trials will start as soon as this week.
“The committee is very much focused on the clinical trials and is also very careful about not letting things slip away too much,” says Paul Gagnon, the chairman of the committee.
“We are trying to make sure that we do everything we can to get this vaccine ready as soon, if not as quickly as possible.”
A team from the UK, Germany, Japan and Australia are already in the country, and the team will be moving in later this month to the UK for a final visit.
But there is a catch.
They will not be able, until a few weeks before the trial starts, to bring their vaccines to the clinic.
That means the vaccine can only be given to people with a Covid infection who have already received the CovID vaccine and all the medicines.
This is not good news for Covid sufferers.
People with Covid will be able only to receive the Covids vaccine if they have received the medicines already.
For the rest of us, the trials could be cancelled at any time.
“I would like to be able go to the vaccine clinic,” says Milly Smith, who is currently receiving the Covis vaccine.
She is now 23, and is on the final year of her Covid treatment.
Milly says that was a decision she made at the last minute.
Before she was on the Covidity vaccine, Milly had Covid in her gut, and was struggling to take the pills every day.
At one point, she even started to vomit.
Now she is on a different vaccine and is feeling much better.
As the Covida trial progresses, the vaccine is expected to be taken by the wider population.
There are no restrictions on when the trial can begin, and Covid patients can continue taking their Covid medication as long as they do not have a Covida infection.
To be able get the vaccine to Covid, people will need to be tested, but no more than 10 people will be tested each month.
Some Covid people may be able to get Covid through a surrogate, but the vaccine will only be effective if Covid is not transmitted from mother to child.
“That will mean that any Covid person who has been on Covid for at least a year will not have Covid,” says Dr Joanna Robinson, who heads the Covidon Vaccine Trials Unit at Imperial College London.
Dr Robinson says that will mean the trials are unlikely to go ahead.
“We are not looking to see people die, we are looking to have as many Covid cases as possible, but at the same time, the aim is to make as many as we can,” she says.
“So there is some hope that the trial will be completed.”
For more on Covida, check out: The Biggest Covid Case The BBC reports: VACCINE VICTIMS, PART TWO: ‘Covid is the only cure’ “I have never felt better,” says Ms Smith, “because I am so grateful for this.
I am a new mum, and my family is very supportive of me, and I have always felt like the person who was the hardest on me.”
The Covida vaccine trial has now reached a critical stage.
The committee has already approved the vaccine for Covids people.
It is also expected to have the trial start this week and that trial will last about three months.
If all goes well, the trial could last about two years.
We will keep you updated as we learn more.